SIMON PEDDER

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Oncotelic Therapeutics, Inc.

Filing Date Source Excerpt
2016-10-03 Simon Pedder Represents shares Dr. Pedder has the right to acquire currently or within 60 days of September 15, 2016, upon the exercise of options.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22